5.36
Schlusskurs vom Vortag:
$5.19
Offen:
$5.23
24-Stunden-Volumen:
30,198
Relative Volume:
0.41
Marktkapitalisierung:
$111.97M
Einnahmen:
$79.89M
Nettoeinkommen (Verlust:
$-12.35M
KGV:
-6.4578
EPS:
-0.83
Netto-Cashflow:
$32.92M
1W Leistung:
+2.29%
1M Leistung:
+28.85%
6M Leistung:
+10.97%
1J Leistung:
+46.85%
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Vergleichen Sie DERM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DERM
Journey Medical Corp
|
5.36 | 111.97M | 79.89M | -12.35M | 32.92M | -0.83 |
![]()
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical CFO Joseph Benesch sells $7,084 in stock - Investing.com India
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 6.5% in January - MarketBeat
Meet Jahkil Jackson - Bold Journey Magazine
Tedy Bruschi: A Champion on a Heart Health Journey - Abbott
Pioneers of today embark on journey to yesteryear - St. Paul Pioneer Press
Strong Growth Potential and Strategic Market Positioning Drive Buy Rating for Journey Medical Corp. - TipRanks
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 14.8% in January - MarketBeat
Journey Medical Corporation's (NASDAQ:DERM) biggest owners are public companies who got richer after stock soared 32% last week - Yahoo Finance
He ruled the operating room and then daytime TV. Now, Dr. Oz is set to take over a $1.5 trillion health agency - STAT
Navigating NLSP Stock: NLS Pharmaceutics Ltd Journey - The InvestChronicle
Short Interest in Journey Medical Co. (NASDAQ:DERM) Grows By 14.8% - Defense World
Journey Medical: FDA Approval For Emrosi Makes This An Exciting Stock (DERM) - Seeking Alpha
Tempus AI, Inc. (TEM): A Bull Case Theory - Yahoo Finance
National Public Health Week 2023 - U.S. Immigration and Customs Enforcement Newsroom
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM) - Yahoo Finance
Sara Saito’s journey from tennis courts in Gunma to promising WTA pro - The Japan Times
Stocks on brokerages’ radar for January 24 - MSN
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
Journey Medical Sets Launch Date for Emrosi, New FDA-Approved Rosacea Treatment - StockTitan
Journey Medical Co. (NASDAQ:DERM) Sees Significant Increase in Short Interest - MarketBeat
Journey Medical Corp (NASDAQ: DERM): Sinking Weak -28.38% In 2025, Outlook Strong - Stocks Register
Intraoperative Imaging Market: The Journey From $2.76 Billion - openPR
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Jumps 0.32 Percent In Recent Trading, What Questions Do You Have? – Stocks Register - Stocks Register
IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register
CIMG Inc (NASDAQ: IMG) Stock: Bulls Should Watch This - Stocks Register
This Data Shows Just How Strong Milestone Pharmaceuticals Inc (NASDAQ: MIST) Stock Is - Stocks Register
No Stopping Allarity Therapeutics Inc (NASDAQ: ALLR)’s Stock Surged? - Stocks Register
What Do Analysts Think Will Happen To Springview Holdings Ltd (NASDAQ: SPHL) - Stocks Register
PDS Biotechnology Corporation (NASDAQ: PDSB): Hidden Gems In A Time Of Volatility - Stocks Register
My journey to becoming a veterinary professional - DVM 360
Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel to Monitor Treatment Journey for Patients with Traumatic Brain Injury and Alzheimer's - Yahoo Finance
Journey Medical Co. (NASDAQ:DERM) Shares Acquired by Geode Capital Management LLC - Defense World
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
LAVA Therapeutics NV (LVTX)’S -5.56% Retreat Makes It Worth Considering Again - Stocks Register
Tillys Inc (TLYS): Major Improvements, Worth A Look - Stocks Register
Journey Medical (NASDAQ:DERM) Shares Down 5.3%Here's Why - MarketBeat
SWK Holdings Provides Portfolio Update - AccessWire
Malaysia’s education, business, healthcare AI journey in 2024 - The Malaysian Reserve
Step into ukiyo-e: A digital journey through Japan’s traditional art form - The Japan Times
Jim Cramer Says CVS Health Corporation (CVS) Is Going To Be ‘Challenged In Every Part Of The Business’ - Yahoo Finance
Bridgebio’s Attruby FDA nod boosts stock; 10 November approvals - BioWorld Online
One Man Shares His Journey With ATTR-CM - Health Central
Journey Medical Decline Means Insider Profits Down To US$101k - Simply Wall St
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
Dassault Systèmes at CES 2025 Unveils the Future of Health and Wellness with AI-Powered Virtual Twins - Dassault Systèmes
Larry Acquarulo ’81Innovates in Medical Plastics - UMass Lowell
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Service Properties Trust (NASDAQ:SVC) - Defense World
Walleye Capital LLC Takes $220,000 Position in The Taiwan Fund, Inc. (NYSE:TWN) - Defense World
GE HealthCare - linkedin
Injection Perfection Medical Spa Unveils Morpheus8 OptimasMax for Comprehensive Aesthetic Treatments. - StreetInsider.com
How we help consumers eat well and support their health - Danone
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):